Breast Cancer Index is a predictive biomarker of treatment benefit and outcome from extended tamoxifen therapy: final analysis of the Trans-aTTom study

John Bartlett, Dennis C. Sgroi, Kai Treuner, Yi Zhang, Tammy Piper, Ranelle C. Salunga, Ikhlaaq Ahmed, Lucy Doos, Sarah Thornber, Karen Taylor, Elena F. Brachtel, Sarah J. Pirrie, Catherine A Schnabel, Daniel Rea

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Breast Cancer Index is a predictive biomarker of treatment benefit and outcome from extended tamoxifen therapy: final analysis of the Trans-aTTom study'. Together they form a unique fingerprint.

Medicine and Dentistry